For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
Take a look at our BETA site and see what we’ve done so far.
Search and browse selected products
Purchase these through your usual distributor
Oncology research often requires working across multiple disciplines to unravel the mechanisms driving cancer. Oncological research may include the study of integrating transcriptomics, proteomics, metabolomics, oncogenic signaling, epigenetics, or immune evasion. Research across these fields has revealed new hallmarks of cancer and emerging targets like CD9 that drive therapy resistance.
We work with key opinion leaders, partner organizations like CRUK, and biopharma companies such as MEDx to understand the current and future needs of the field. With these partnership influences on our pipeline, we are able to develop more comprehensively validated reagents to both established and novel cancer targets.
We can support you through even the most challenging project with robust recombinant reagents, our extensive technical expertise, and partnering services that integrate our reagents into your diagnostic assays.
Discover all-new recombinant antibody launches to Oncology targets
For more information on collaboration or to discuss your project, get in touch with us at oncology@abcam.com.
Learn more about the complex interplay of the tumor, stromal cells, and immune cells within the TME with our pathway.
Use our cancer immunohistochemistry (IHC) guide to select the right biomarker and the best IHC antibody for your research.
Everything you need to unlock the power of immuno-oncology biomarkers and generate data you can trust.
Explore both interactive and downloadable pathways across topics like DNA damage response, autophagy and Wnt featuring key products.
Professor Wendy Fantl describes her team’s research on ovarian cancer intra-tumoral heterogeneity and the critical role of CD9 in ovarian cancer.
From fundamental to translational research and clinical applications, share your findings and ideas with the research community.
638110157870000000
Article
638102496690000000
Article
638013663800000000
Article
637997894040000000
Article
Product
637836247950000000
Article
637807118770000000
Video
637807118630000000
Video
637596259800000000
Protocol
637515030450000000
Pathway
637432970610000000
Article
637419804620000000
Article
637407886520000000
Video
637048340620000000
Article
637026744410000000
Product
636940308310000000
Product
636940303210000000
Product
636940302760000000
Product
636940301900000000
Product
636940301410000000
Product
636940298300000000
Product
636940297100000000
Product
636892089380000000
Product
636892088370000000
Product
636892065780000000
Product
636887782870000000
Product
636887781890000000
Product
636881624260000000
Product
636880053220000000
Product
636846073170000000
Product
636836808750000000
Product
636836807640000000
Product
636836800370000000
Product
635626981670000000
Article